Back to results

Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma

Primary Purpose

Glaucoma

Status

Completed

Phase

Locations

Greece

Study Type

Observational

Intervention

About this trial

This is an observational trial for Glaucoma focused on measuring Greece, Ophthalmology, Glaucoma, Generics, Perception

Eligibility Criteria

25 Years - 67 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Licensed Registration to Greek Ophthalmology Council

Exclusion Criteria:

Sites / Locations

University Hospital of Alexandroupolis

Outcomes

Primary Outcome Measures

Generic Perception

Secondary Outcome Measures

Full Information

NCT ID

NCT01855802

First Posted

April 30, 2013

Last Updated

January 14, 2017

Sponsor

Democritus University of Thrace

1. Study Identification

Unique Protocol Identification Number

NCT01855802

Brief Title

Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma

Official Title

Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma

Study Type

Observational

2. Study Status

Record Verification Date

January 2017

Overall Recruitment Status

Completed

Study Start Date

April 2013 (undefined)

Primary Completion Date

September 2013 (Actual)

Study Completion Date

October 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Principal Investigator

Name of the Sponsor

Democritus University of Thrace

4. Oversight

Data Monitoring Committee

5. Study Description

Brief Summary

This attempts to investigate the perceptions of Greek Ophthalmologists regarding generics prescription in glaucoma by means of a structured questionnaire.

Detailed Description

The following dimensions will be recorded Overall physician's empathy regarding generics in glaucoma Physician's prescribing habits regarding generics in glaucoma Physician's perceptions regarding generics cost-effectiveness in glaucoma Physician's perceptions regarding adequacy of Greek regulatory authorities (generic market in glaucoma) Physician's perceptions regarding adequacy of European regulatory authorities (generic market in glaucoma)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Glaucoma

Keywords

Greece, Ophthalmology, Glaucoma, Generics, Perception

7. Study Design

Enrollment

70 (Actual)

Primary Outcome Measure Information:

Title

Generic Perception

Time Frame

3 months

10. Eligibility

Sex

All

Minimum Age & Unit of Time

25 Years

Maximum Age & Unit of Time

67 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Licensed Registration to Greek Ophthalmology Council Exclusion Criteria: -

Study Population Description

Greek Medical Council Members

Sampling Method

Non-Probability Sample

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

Georgios Labiris, PhD

Organizational Affiliation

Democritus University of Thrace, Medical School

Official's Role

Principal Investigator

Facility Information:

Facility Name

University Hospital of Alexandroupolis

City

Alexandroupolis

State/Province

Evros

ZIP/Postal Code

68100

Country

Greece

12. IPD Sharing Statement

Citations:

PubMed Identifier

26457225

Citation

Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, Niakas D. Greek Physicians' Perceptions on Generic Drugs in the Era of Austerity. Scientifica (Cairo). 2015;2015:251792. doi: 10.1155/2015/251792. Epub 2015 Sep 17.

Results Reference

result

Learn more about this trial

Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma

We'll reach out to this number within 24 hrs